Page 361 - Multidisipliner Covid 19
P. 361

COVID-19 Pandemisinde Nörolojik Hastal›klar


                      study. Eur Arch Otorhinolaryngol. 2020; Apr 6:1-11.
                   7.  Passali GC, Bentivoglio AR.  Comment to the article “Olfactory and
                      gustatory dysfunctions as a clinical presentation of mild-to-moderate
                      forms of the coronavirus disease (COVID-19): a multicenter European
                      study”. Eur Arch Otorhinolaryngol. 2020; May 7: 1-2.
                   8.  Giacomelli A, Pezzati L, Conti F, Bernacchia D, et al.  Self-reported
                      olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional
                      study. Clin Infect Dis. 2020; Mar 26:ciaa330.
                   9.  Doobay MF, Talman LS, Obr TD, et al. Differential expression of neu-
                      ronal ACE2 in transgenic mice with overexpression of the brain renin-
                      angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007;29(1):
                      R373–R381.
                   10. Chen T, Wu Di, Chen H, et al. Clinical characteristics of 113 deceased
                      patients with coronavirus disease 2019: retrospective study. BMJ. 2020;
                      368: m1091.
                   11. Chan JF, Yuan S, Kok KH et al. A familial cluster of pneumonia associated
                      with the 2019 novel coronavirus indicating  person-to-person transmis-
                      sion: a study of a family cluster. Lancet . 2020;395(10223):514–523.
                   12. Li W, Zhang C, Sui J, et al. Receptor and viral determinants of SARS-
                      coronavirus adaptation to human ACE2. EMBO J. 2005; 24(8):1634–1643.
                   13. Cao Y, Li L, Feng Z, et al.  Comparative genetic analysis of the novel
                      coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different
                      populations. Cell Discov. 2020;6:11.
                   14. Wilson MP, Jack AS. Coronavirus disease (COVID-19) in neurology
                      and neurosurgery: A scoping review of the early literature.  Clin Neurol
                      Neurosurg. 2020;193:105866.
                   15. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic
                      complications in critically ill ICU patients with COVID-19. Thromb
                      Res 2020; 191:145-147.
                   16. Mao L, Wang M, Chen S, et al. Neurological Manifestations of
                      Hospitalized Patients with COVID-19 in Wuhan, China: a Retrospective
                      Case Series Study. JAMA Neurol. 2020  Apr 10;e201127.
                   17. Li Y, Wang M, Zhou Y, et al. Acute Cerebrovascular Disease Following
                      COVID-19: A Single Center, Retrospective, Observational Study. BMJ
                      Open Diabetes Res Care. 2020;8(1):e001343.
                   18. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with
                      2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506.




                       360
   356   357   358   359   360   361   362   363   364   365   366